Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Perennial Real Estate Announces $1.2 Billion China Healthcare Center JV

publication date: Jan 3, 2018

Perennial Real Estate Holdings, a Singapore company, announced a $1.2 billion joint venture that will acquire and develop healthcare centers in China. It plans to concentrate on integrated mixed-use developments, centered around healthcare, that are connected to China high speed railway stations. Perennial is already building two such properties, one in Chengdu and the other in Xi'an. Its major partner in the JV will be Shun Tak Holdings, a Hong Kong conglomerate. Perennial contributed $225 million to the first close of the JV, which is $500 million. More details....

Stock Symbols: (SGX: 40S) (HKSE 242)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.